GlassScriptPhysician profile
John Y Choi
NPI 1205862869
$2,092.68
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,521 · 2020: $83.10 · 2022: $15.24 · 2023: $167 · 2024: $306.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $473.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $473.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $488.47 | 2022-2024 | Stealthstation S8 Platform, Endurant Iis, Mazor X System |
| Supernus Pharmaceuticals, INC. | $302.98 | 2019-2020 | |
| Genzyme Corporation | $212.10 | 2019 | |
| Amgen INC. | $143.36 | 2019 | |
| Csl Behring | $125.63 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $93.21 | 2019 | |
| Sunovion Pharmaceuticals INC. | $87.87 | 2019 | |
| Genentech USA, INC. | $83.08 | 2019 | |
| Greenwich Biosciences, INC. | $81.53 | 2019 | |
| Avanir Pharmaceuticals, INC. | $64.75 | 2019 | |
| Adamas Pharmaceuticals, INC. | $62.36 | 2019 | |
| Ucb, INC. | $49.34 | 2019 | |
| Biogen, INC. | $44.40 | 2019 | |
| Grifols USA, LLC | $42.70 | 2019 | |
| Lundbeck LLC | $32.93 | 2019 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz North America, INC. | $28.91 | 2019 | |
| Neurocrine Biosciences, INC. | $27.86 | 2019 | |
| Lilly USA, LLC | $20.19 | 2019 | |
| Boston Scientific Corporation | $19.80 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $19.23 | 2020 | |
| Aquestive Therapeutics, INC. | $18.45 | 2019 | |
| Acorda Therapeutics, INC | $16.72 | 2019 | |
| Mallinckrodt Enterprises LLC | $13.50 | 2019 | |
| Novartis Pharmaceuticals Corporation | $13.31 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Choi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.